))
a16z: a16z Podcast: Mindsets for Engineering Biology
Archived series ("HTTP Redirect" status)
Replaced by: owltail.com
When?
This feed was archived on March 15, 2018 15:41 (
Why? HTTP Redirect status. The feed permanently redirected to another series.
What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 196949401 series 1984869
Content provided by Best Podcasts Similar Masters Of Scale - 3 Episodes a week. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Best Podcasts Similar Masters Of Scale - 3 Episodes a week or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Published on 06 Oct 2017. Head of the largest bioengineering lab in the world, former chairman of the FDA and one of the few recipients of the National Medals of Science and of Technology and Innovation, Bob Langer's work has spanned multiple fields and settings and has been applied across numerous fields, from pharmaceutical to chemical, biotechnology to medical device companies. What does it mean to move across disciplines like this, from science to engineering, both in the lab and into the field? In this conversation with general partner and head of the a16z bio fund Vijay Pande (with Hanne Tidnam), Langer and Pande share the challenges and opportunities as people move across different disciplines, as well as the changing mindsets for innovation as applied to biotech: first principles, "rational" biology, do no harm, and others. At the heart of it all is "the interface of engineering and materials" in biology and healthcare innovation. Especially as, thanks to tech, biology shifts from empirical study to engineering -- not just in startups but in academia too. Yet does that make the work too "translational"? And what of regulation? The guests on this episode explore all of these themes, and more.
…
continue reading
65 episodes
Share
